2020 events conditioned the congress of the European Society of Human Reproduction and Embryology (ESHRE) to be held online for the first time in history. Among different research projects developed at Instituto Bernabeu that its scientific committee has accepted to share with the community, there is a report on the evaluation of the β-hCG pregnancy hormone value as a predictor of the evolution of the pregnancy
Dr. Juan Carlos Castillo will present an Oral Communication at the next ESHRE Meeting of the latest research paper “Natural micronized progesterone versus a GnRH antagonist in egg-donation cycles. An extended experience ”; a new advance to improve medication in egg donors.
The current circumstances have made this scientific event, the most important in the field of Reproductive Medicine, to be held extraordinarily online this year.
Instituto Bernabeu has participated in the creation of the Guide to Practical Care of the Obstetric and Gynecological Ultrasound section of the Spanish Society of Obstetrics and Gynecology.
Optimizes and improves cycles for egg donors, oncology patients, women with low reserve, immature oocyte syndrome and empty follicle syndrome
The international medical journal Upsala Journal of Medical Sciences has just published a research paper led by Instituto Bernabeu entitled "Gonadotropin-releasing hormone agonist ovulation trigger — beyond OHSS prevention". It was developed by Instituto Bernabeu gynecologist, expert in ovarian stimulation, Dr. Juan Carlos Castillo with the participation of Thor Haahr, María Martínez-Moya and Peter Humaidan. The goal of this review is to present the advantages of the gonadotropin-releasing hormone agonist (GnRHa) trigger in ovarian stimulation during reproductive medicine treatment. It highlights that its role goes beyond the prevention of ovarian hyperstimulation syndrome (OHSS).